SRAMF (Sisram Medical) Common Stock: $1.3 Mil (As of Dec. 2025)


SRAMF Sisram Medical Ltd SRAMF
60 GF Score
Price $0.44
GF Value $0.94
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is Sisram Medical Common Stock?

Sisram Medical SRAMF 60 Common Stock is $1.3 Mil as of Dec. 2025. GuruFocus rates SRAMF with a GF Score™ of 60/100 and a GF Value™ of $0.94 (Significantly Undervalued). The stock has 5 warning signs investors should review.

Sisram Medical's quarterly common stock stayed the same from Dec. 2024 ($1.3 Mil) to Jun. 2025 ($1.3 Mil) and stayed the same from Jun. 2025 ($1.3 Mil) to Dec. 2025 ($1.3 Mil).

Sisram Medical's annual common stock stayed the same from Dec. 2023 ($1.3 Mil) to Dec. 2024 ($1.3 Mil) and stayed the same from Dec. 2024 ($1.3 Mil) to Dec. 2025 ($1.3 Mil).

Sisram Medical Common Stock Historical Data

* Premium members only.

The historical data trend for Sisram Medical's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sisram Medical Common Stock Chart

Sisram Medical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.33 1.33 1.33 1.33 1.33

Sisram Medical Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.33 1.33 1.33 1.33 1.33
SRAMF
60GF Score
Sisram Medical Ltd SRAMF
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sisram Medical Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $1.3 Mil mean?
Sisram Medical (SRAMF) has a Common Stock of $1.3 Mil as of Dec. 2025. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Sisram Medical and its competitors.
Is Sisram Medical's Common Stock too high?
Sisram Medical's current Common Stock is $1.3 Mil. Overall, Sisram Medical has a GF Score™ of 60/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sisram Medical's Common Stock compare to ABT and SYK?
Sisram Medical's Common Stock of $1.3 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Medical Devices & Instruments company?
A good Common Stock depends on the Medical Devices & Instruments industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Sisram Medical and its competitors. Sisram Medical's current Common Stock is $1.3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sisram Medical stock overvalued right now?
Based on GuruFocus' analysis, Sisram Medical (SRAMF) is currently considered Significantly Undervalued. The stock's GF Value™ is $0.94, compared to a current price of $0.44 — trading 53.4% below its estimated fair value. The current Common Stock is $1.3 Mil. Sisram Medical's overall GF Score™ is 60/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Sisram Medical (SRAMF), the current Common Stock is $1.3 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sisram Medical (SRAMF) Overvalued in 2026?

Based on GuruFocus' analysis, Sisram Medical stock appears to be undervalued. The current stock price of $0.44 is trading 53.4% below its estimated GF Value™ of $0.94. GuruFocus considers Sisram Medical to be Significantly Undervalued.

Key valuation signals for SRAMF:

  • Common Stock: $1.3 Mil
  • GF Value™: $0.94 vs. price of $0.44 (53.4% below fair value)
  • GF Score™: 60/100 with 5 warning signs

No single metric tells the full story. See the SRAMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sisram Medical Business Description

Other Exchanges 01696:Hong Kong
Address HaHarash Street 18, Ofek Building 15, Industrial Park, Caesarea, ISR, 3079895
Sisram Medical Ltd is an investment holding company specializing in medical technology for healthcare. The Company is involved in research, development, design, manufacture, sale and marketing of medical aesthetics and dental equipment, home use devices, injectables and cosmeceuticals products. The company's products include Soprano Titanium, Colibri technology, and others. Some of the company's brands are Alma, Soprano, Copulla, and LMNT. It operates through the following geographical segments: North America which is its key revenue generating market, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
60GF Score

Get the complete analysis for SRAMF

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.44
Price
$0.94
GF Value